Vestmark Advisory Solutions’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.78M Buy
22,565
+201
+0.9% +$39.4K 0.04% 395
2026
Q1
$4.38M Buy
22,364
+5,488
+33% +$1.07M 0.05% 381
2025
Q4
$2.93M Buy
16,876
+15,741
+1,387% +$2.87M 0.04% 463
2025
Q3
$216K Sell
1,135
-8,155
-88% -$1.45M ﹤0.01% 862
2025
Q2
$1.67M Buy
+9,290
New +$1.61M 0.02% 403
2021
Q4
Sell
-2,118
Closed -$308K 847
2021
Q3
$308K Buy
+2,118
New +$310K 0.02% 657

Other funds holding DGX

Vestmark Advisory Solutions's DGX Position: Q2 2026 in Review

Vestmark Advisory Solutions increased its Quest Diagnostics (DGX) stake by 0.9% in Q2 2026, buying an estimated $39.4K and bringing the position to 22,565 shares worth $4.78M. The position accounts for 0.04% of the portfolio, ranked #395.

Vestmark Advisory Solutions first reported a position in DGX in Q3 2021 and has held it in 6 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Vestmark Advisory Solutions held 22,565 shares of Quest Diagnostics worth $4.78M as of Q2 2026.
  • Vestmark Advisory Solutions bought 201 Quest Diagnostics shares in Q2 2026, an estimated $39.4K.
  • Quest Diagnostics made up 0.04% of Vestmark Advisory Solutions's portfolio in Q2 2026, its #395 holding.
  • Vestmark Advisory Solutions first reported a position in Quest Diagnostics in Q3 2021 and has held it in 6 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Vestmark Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.